Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1978 1
1992 1
1995 2
1996 1
1998 5
1999 1
2000 3
2001 6
2002 5
2003 9
2004 3
2005 3
2008 2
2009 10
2010 8
2011 7
2012 6
2013 9
2014 2
2015 15
2016 12
2017 7
2018 3
2019 2
2020 3
2021 4
2022 5
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.
Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes.
Khoo A, Govindarajan M, Qiu Z, Liu LY, Ignatchenko V, Waas M, Macklin A, Keszei A, Main BP, Yang L, Lance RS, Downes MR, Semmes OJ, Vesprini D, Liu SK, Nyalwidhe JO, Boutros PC, Kislinger T. Khoo A, et al. Among authors: lance rs. bioRxiv [Preprint]. 2023 Jul 25:2023.07.23.550214. doi: 10.1101/2023.07.23.550214. bioRxiv. 2023. PMID: 37546794 Free PMC article. Preprint.
Molecular pathology of prostate cancer.
Cazares LH, Drake RR, Esquela-Kirscher A, Lance RS, Semmes OJ, Troyer DA. Cazares LH, et al. Among authors: lance rs. Cancer Biomark. 2010;9(1-6):441-59. doi: 10.3233/CBM-2011-0181. Cancer Biomark. 2010. PMID: 22112489 Review.
A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors.
Iadonato S, Ovechkina Y, Lustig K, Cross J, Eyde N, Frazier E, Kabi N, Katz C, Lance R, Peckham D, Sridhar S, Talbaux C, Tihista I, Xu M, Guillaudeux T. Iadonato S, et al. Among authors: lance r. Front Immunol. 2023 Dec 12;14:1311658. doi: 10.3389/fimmu.2023.1311658. eCollection 2023. Front Immunol. 2023. PMID: 38152397 Free PMC article.
An open-source framework for synthetic post-dive Doppler ultrasound audio generation.
Le DQ, Hoang AH, Azarang A, Lance RM, Natoli M, Gatrell A, Blogg SL, Dayton PA, Tillmans F, Lindholm P, Moon RE, Papadopoulou V. Le DQ, et al. Among authors: lance rm. PLoS One. 2023 Apr 27;18(4):e0284922. doi: 10.1371/journal.pone.0284922. eCollection 2023. PLoS One. 2023. PMID: 37104279 Free PMC article.
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.
Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, Smith E, Tenggara I, Zhang X, Carroll PR, Chan JM, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, Feng Z, True LD, Brooks JD. Hawley S, et al. Among authors: lance r. Adv Anat Pathol. 2013 Jan;20(1):39-44. doi: 10.1097/PAP.0b013e31827b665b. Adv Anat Pathol. 2013. PMID: 23232570 Free PMC article. Review.
Human Injury Criteria for Underwater Blasts.
Lance RM, Capehart B, Kadro O, Bass CR. Lance RM, et al. PLoS One. 2015 Nov 25;10(11):e0143485. doi: 10.1371/journal.pone.0143485. eCollection 2015. PLoS One. 2015. PMID: 26606655 Free PMC article.
132 results